Evidence map›Paper›PMID 37431575›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2023

Ethanol inhibits pancreatic acinar cell autophagy through upregulation of ATG4B, mediating pathological responses of alcoholic pancreatitis.

Olga A Mareninova, Sophie R Gretler, Grace E Lee, Michael Pimienta, Yueqiu Qin, Jason M Elperin, Jinliang Ni, Zsolt Razga, Anna S Gukovskaya, Ilya Gukovsky

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Genetic and pharmacologic modulations elucidate NRF2 protective role in acute pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Olga A MareninovaDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.ORCID 0000-0003-0881-4079
Sophie R GretlerDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Grace E LeeDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Michael PimientaDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Yueqiu QinDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Jason M ElperinDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Jinliang NiDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.
Zsolt RazgaInstitute of Pathology, University of Szeged, Szeged, Hungary.
Anna S GukovskayaDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.ORCID 0000-0003-3737-5335
Ilya GukovskyDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States.ORCID 0000-0002-6124-6333
University of California, Los Angeles · USUniversity of Szeged · HU

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Vector and Human Acinar CoreP01DK098108 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KARIN, MICHAEL · 2014 to 2018
$8.1M
Calcineurin in pancreatitisR01DK093491 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUSAIN, SOHAIL Z · 2011 to 2020
$3.7M
Impaired autophagy, mitochondrial dysfunction, and inflammation in pancreatitisR01DK131111 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GUKOVSKY, ILYA, LEE, BOMI · 2022 to 2025
$1.5M
Lysosomal Damage, Impaired Autophagy, and Alcoholic PancreatitisR01AA019730 · NIAAA · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GUKOVSKY, ILYA, MARENINOVA, OLGA A · 2011 to 2015
$1.4M
Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitisR01DK131493 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANNA S. GUKOVSKAYA · 2023 to 2026
$1.4M
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approachI21BX006151 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GUKOVSKAYA, ANNA S. · 2023 to 2024
–
BLRD VA I01 BX004306BLRD VA I21 BX006151BLRD VA IK6 BX005793NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA019730NIDDK NIH HHS P01 DK098108NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK093491NIDDK NIH HHS R01 DK131111NIDDK NIH HHS R01 DK131493
6 · The paper itself

Abstract

Excessive alcohol intake is a major risk factor for pancreatitis, sensitizing the exocrine pancreas to stressors by mechanisms that remain obscure. Impaired autophagy drives nonalcoholic pancreatitis, but the effects of ethanol (EtOH) and alcoholic pancreatitis on autophagy are poorly understood. Here, we find that ethanol reduces autophagosome formation in pancreatic acinar cells, both in a mouse model of alcoholic pancreatitis induced by a combination of EtOH diet and cerulein (a CCK ortholog) and in EtOH+CCK-treated acinar cells (ex vivo model). Ethanol treatments decreased pancreatic level of LC3-II, a key mediator of autophagosome formation. This was caused by ethanol-induced upregulation of ATG4B, a cysteine protease that, cell dependently, regulates the balance between cytosolic LC3-I and membrane-bound LC3-II. We show that ATG4B negatively regulates LC3-II in acinar cells subjected to EtOH treatments. Ethanol raised ATG4B level by inhibiting its degradation, enhanced ATG4B enzymatic activity, and strengthened its interaction with LC3-II. We also found an increase in ATG4B and impaired autophagy in a dissimilar, nonsecretagogue model of alcoholic pancreatitis induced by EtOH plus palmitoleic acid. Adenoviral ATG4B overexpression in acinar cells greatly reduced LC3-II and inhibited autophagy. Furthermore, it aggravated trypsinogen activation and necrosis, mimicking key responses of ex vivo alcoholic pancreatitis. Conversely, shRNA Atg4B knockdown enhanced autophagosome formation and alleviated ethanol-induced acinar cell damage. The results reveal a novel mechanism, whereby ethanol inhibits autophagosome formation and thus sensitizes pancreatitis, and a key role of ATG4B in ethanol's effects on autophagy. Enhancing pancreatic autophagy, particularly by downregulating ATG4B, could be beneficial in mitigating the severity of alcoholic pancreatitis.

Indexed as

Cysteine ProteasesPancreatitis, AlcoholicAcinar CellsAnimalsAutophagyAutophagy-Related ProteinsCysteine EndopeptidasesEthanolHumansMiceUp-RegulationATG4B protein, humanAutophagy-Related ProteinsCysteine EndopeptidasesCysteine ProteasesEthanolalcoholATG4Bautophagycaspasepancreas

Identifiers

PMID37431575
PMCPMC10511161
OpenAlexW4383872013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.